drugset / Trial / NCT07457008
Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
To evaluate the safety and tolerability of multiple intravenous infusions of Ginkgolide B Injection in healthy Chinese participants, as well as to assess the pharmacokinetic (PK) characteristics following single and multiple doses.
Timeline
- Start
- 2021-07-01
- Primary completion
- 2021-09-03
- Completion
- 2021-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgolide B | Unknown | 10 mg | Intravenous |
| Subject | Ginkgolide B | Unknown | 20 mg | Intravenous |
| Subject | Ginkgolide B | Unknown | 30 mg | Intravenous |
Indications
No indication recorded.